News

Balchem Corporation to Host Q3 2025 Financial Results Call

Balchem Corporation to Host Q3 2025 Financial Results Call

Balchem Corporation's Upcoming Conference Call

Balchem Corporation (NASDAQ: BCPC) is excited to announce that it will host a conference call to review its financial results for the third quarter of 2025. The call is scheduled for October 21, 2025, at 11:00 AM Eastern Time. During this event, Ted Harris, the Chairman of the Board, President and CEO, along with Martin Bengtsson, the CFO, will share insights and discuss performance metrics from the last quarter.

What to Expect During the Call

Participants can expect Balchem to publish third quarter results right before the market opens on the same day. The detailed press release, which includes financial exhibits, will be made available on the company's official website prior to the call, providing helpful context for investors and analysts who wish to stay informed about the company’s latest developments.

How to Join the Call

Institutional investors, analysts, and other members of the financial community are invited to participate in the call. They can join by dialing 800-715-9871 (toll-free in the USA/Canada), +1-646-307-1963 (USA/International), or 647-932-3411 (Canada/Toronto) at least five minutes before the start time. For those who prefer to listen online, a live webcast will be available, allowing a broader audience to enjoy the discussion.

Company Overview

Balchem Corporation specializes in developing, manufacturing, and marketing unique specialty ingredients aimed at enhancing global health and well-being. The company's offerings span across several industries and are categorized into three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. Each segment focuses on creating and supplying high-quality solutions tailored to various customer needs.

Human Nutrition & Health Segment

This segment stands out by offering customized ingredient systems targeted for food and beverage industries, along with essential nutrients for supplements and pharmaceuticals. With a commitment to innovation, Balchem continually seeks to expand its product range to benefit consumers around the world.

Animal Nutrition & Health Segment

Balchem also plays a significant role in the animal health market, producing and distributing a variety of products that cater to the needs of livestock and pets. This dedication establishes Balchem as an important player in animal nutrition, contributing to better health outcomes.

Specialty Products Division

In addition to the nutrition sectors, Balchem’s Specialty Products division provides various specialty-packaged chemicals for healthcare and other applications. The company’s expertise also extends to the micronutrient agricultural market, offering chelated minerals that enhance plant health and growth.

Investor Relations and Contact Information

If you have any inquiries, please reach out to:

Jacqueline Yarmolowicz, Executive Assistant
Telephone: 845-326-5600
Email: jyarmolowicz@balchem.com

Frequently Asked Questions

When will Balchem Corporation's Q3 2025 results be announced?

The results will be announced on October 21, 2025, before the market opens.

How can I join the conference call?

Dial 800-715-9871 (toll-free in the USA/Canada) or join via the live webcast on the company’s website.

Who will host the conference call?

The call will be hosted by Ted Harris, Chairman of the Board, and Martin Bengtsson, CFO.

What are the main segments of Balchem Corporation?

Balchem operates through three main segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

How can I contact Balchem Corporation for more information?

You can contact Jacqueline Yarmolowicz at 845-326-5600 or via email at jyarmolowicz@balchem.com.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Advanta's Game-Changer: Acquiring Misr Hytech to Expand in Africa

Updated Category News Views 151

Advanta's Strategic Move into Africa Alright, let's cut to the chase. Advanta is making a big splash with its acquisition of Misr Hytech, a move that's going to shake things up in Africa's agricultural sector. This isn't just another merger to gloss over with your morning coffee. We're talking about a deal that's supposed to wrap up by January 31, 2027, bringing together...

Continue Reading
Perpetua Reports Q3 2026 Results, Progress on Project

Updated Category News Views 95

A Steady Climb for Perpetua Resources It's like watching a boxer steadily climb the ranks, waiting for the big title fight. That's the scene with Perpetua Resources (NASDAQ:PPTA) as their Q3 2026 financial results hit the wires. No confetti cannons this time, just solid, gritty steps towards a promising future. Q3 Financial Results: A Prudent Path The financials for...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
HONGQI's EHS4 Launch in Europe: Bridging East and West

Updated Category News Views 9

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 280

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading
Samuel Oschin Center Opens, Promising Wonder

Updated Category News Views 192

A Grand New Space for Space Well, here's a sight for sore eyes—California Science Center's Samuel Oschin Air and Space Center just swung its doors open wide, and boy, it's a beast of a place. Housing a spectacle like the Space Shuttle Endeavour in a vertical launch position, it's as if they've reached up and snagged a piece of the sky itself for their exhibits. They're...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Chime Joins S&P MidCap 400 Amid Merger Jostle

Updated Category News Views 194

Index Shake-Up: Who's In, Who's Out? Hold onto your hats, folks—big changes are coming to the S&P MidCap 400! Chime Financial Inc. is crashing the party, taking a seat at the table, as NorthWestern Energy Group gets the boot. Now, if that doesn’t grab your attention, I don’t know what will. You've got to appreciate the chaos and opportunities that come with a roster...

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 132

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Breakthrough T1D Pushes Global T1D Awareness Forward

Updated Category News Views 150

Shining a Light on T1D with Global Efforts In a world where a change in lifestyle can happen at the drop of a hat, Breakthrough T1D is making waves by expanding their global "See T1D" campaign in honor of World Diabetes Day. This isn't your run-of-the-mill awareness push—this is about propelling an understanding of what life truly entails for those living with type 1...

Continue Reading

Top 5 Most Recently Viewed Articles

CrossCountry Mortgage Expands Asset Management with Growth

Updated Category News Views 348

Expansion of CrossCountry Capital CrossCountry Capital, part of CrossCountry Mortgage, is making headlines with its impressive growth. Recently, they announced that they have received over $1 billion in equity capital commitments, paving the way for more than $20 billion in new loan investments. This development reflects the rapid evolution of their asset management...

Continue Reading
PBIRx Strengthens Leadership to Elevate Client Services

Updated Category News Views 65

PBIRx, Inc. made waves in the pharmacy benefit consulting world back in 2024 by promoting Stacy Mathews to Director of Account Management. You know what that means? Major shifts on the horizon for this player trying to navigate an ever-changing healthcare landscape. Stacy Mathews: The New Force Behind PBIRx Stacy’s rise within PBIRx wasn’t just a lucky break; she came...

Continue Reading
NatGold Digital Crosses Into European Crypto Territory

Updated Category News Views 93

Amidst the ever-turning gears of digital finance, NatGold Digital has staked its claim, looking to make waves across the Atlantic. As per the word from Miami, they're bringing their fancy digital mining show to the biggest digital asset parade grounds: Europe. It's not just a dip of the toe, either—they're gunning for the whole European Economic Area. A bit ambitious,...

Continue Reading
Cotti's Journey to 10,000 Stores: Challenges and Strategies Ahead

Updated Category News Views 581

Cotti's Journey to Milestone Achievement Cotti Coffee has recently celebrated a remarkable achievement, reaching the milestone of 10,000 stores in a span of just two years. This expansion has been fueled by a fierce price war against its rival, Luckin Coffee. While this rapid growth is impressive, questions arise regarding the sustainability of Cotti's low-price strategy...

Continue Reading
CIRO Schedules Hearing for Allegations Against Abid Hossain

Updated Category News Views 145

Overview of the Disciplinary Hearing A hearing has been set before a panel of the Canadian Investment Regulatory Organization (CIRO) regarding allegations against Abid Hossain. This case arises under the Mutual Fund Dealer Rules, highlighting the importance of integrity in financial services. Public Access to the Hearing The upcoming disciplinary hearing will be open to...

Continue Reading